Akero Therapeutics, Inc.
US ˙ NasdaqGS ˙ US00973Y1082
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityAKRO / Akero Therapeutics, Inc.
InstitutionTd Asset Management Inc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Td Asset Management Inc closes position in AKRO / Akero Therapeutics, Inc.

On February 10, 2026 - Td Asset Management Inc filed a 13F-HR form disclosing ownership of 0 shares of Akero Therapeutics, Inc. (US:AKRO) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 10, 2025 disclosing 188,844 shares of Akero Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-10 2025-12-31 13F AKERO THERAPEUTICS COM 00973Y108 0 -188,844 -100.00 0 -100.00
2025-11-10 2025-09-30 13F AKERO THERAPEUTICS COM 00973Y108 188,844 -2,604 -1.36 8,966 -12.23 0.0073
2025-07-28 2025-06-30 13F AKERO THERAPEUTICS COM 00973Y108 191,448 -17,400 -8.33 10,216 20.83 0.0087
2025-05-07 2025-03-31 13F AKERO THERAPEUTICS COM 00973Y108 208,848 39,194 23.10 8,454 79.15 0.0078
2025-02-11 2024-12-31 13F AKERO THERAPEUTICS COM 00973Y108 169,654 46,200 37.42 4,720 35.37 0.0042
2024-11-01 2024-09-30 13F AKERO THERAPEUTICS COM 00973Y108 123,454 -31,138 -20.14 3,486 -3.86 0.0031
2024-08-02 2024-06-30 13F AKERO THERAPEUTICS COM 00973Y108 154,592 29,600 23.68 3,627 14.86 0.0034
2024-05-08 2024-03-31 13F AKERO THERAPEUTICS COM 00973Y108 124,992 30,790 32.69 3,157 43.57 0.0029
2024-02-12 2023-12-31 13F AKERO THERAPEUTICS COM 00973Y108 94,202 -31,890 -25.29 2,200 -65.52 0.0022
2023-10-27 2023-09-30 13F AKERO THERAPEUTICS COM 00973Y108 126,092 63,346 100.96 6,378 117.72 0.0077
2023-08-09 2023-06-30 13F AKERO THERAPEUTICS COM 00973Y108 62,746 4,724 8.14 2,930 32.00 0.0033
2023-05-10 2023-03-31 13F AKERO THERAPEUTICS COM 00973Y108 58,022 5,600 10.68 2,220 -22.74 0.0027
2023-02-07 2022-12-31 13F AKERO THERAPEUTICS COM 00973Y108 52,422 33,300 174.14 2,873 403.86 0.0035
2022-11-07 2022-09-30 13F AKERO THERAPEUTICS COM 00973Y108 19,122 19,122 570 0.0007
2022-05-10 2022-03-31 13F AKERO THERAPEUTICS COM 00973Y108 0 -25,102 -100.00 0 -100.00
2022-02-10 2021-12-31 13F AKERO THERAPEUTICS COM 00973Y108 25,102 0 0.00 531 -5.35 0.0004
2021-11-09 2021-09-30 13F AKERO THERAPEUTICS COM 00973Y108 25,102 0 0.00 561 4.28 0.0006
2021-08-11 2021-06-30 13F AKERO THERAPEUTICS COM 00973Y108 25,102 0 0.00 538 -26.10 0.0005
2021-05-14 2021-03-31 13F AKERO THERAPEUTICS COM 00973Y108 25,102 5,497 28.04 728 43.87 0.0008
2021-02-16 2020-12-31 13F AKERO THERAPEUTICS COM 00973Y108 19,605 4,000 25.63 506 5.42 0.0006
2020-11-10 2020-09-30 13F AKERO THERAPEUTICS COM 00973Y108 15,605 6,883 78.92 480 121.20 0.0007
2020-08-13 2020-06-30 13F AKERO THERAPEUTICS COM 00973Y108 8,722 8,722 217 0.0003
2020-05-14 2020-03-31 13F AKERO THERAPEUTICS COM 00973Y108 0 -10,322 -100.00 0 -100.00
2020-02-11 2019-12-31 13F AKERO THERAPEUTICS COM 00973Y108 10,322 0 0.00 229 -2.55 0.0003
2019-11-07 2019-09-30 13F AKERO THERAPEUTICS COM 00973Y108 10,322 10,322 235 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.